Skip to main content
An official website of the United States government

CDK1/2/4 inhibitor AG-024322

A cyclin-dependent kinase (CDK) inhibitor with antineoplastic activity. AG-024322 selectively inhibits cyclin-dependent kinases (particularly CDK1,2 and 4), enzymes that regulate cell cycle progression. Inhibition of CDK may result in cell cycle arrest, induction of apoptosis, and inhibition of DNA replication and tumor cell proliferation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Code name:AG-24322
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search